Surveillance report on interim COVID-19 vaccination coverage in the EU/EEA, August 2024 – January 2025
This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2024 and 17 January 2025, with some variation in dates between countries.
Key facts
- This report presents an interim description of COVID-19 vaccine coverage in the European Union/ European Economic Area (EU/EEA) between 1 August 2024 and 17 January 2025. More consolidated data are expected in the coming weeks and months.
- During the reporting period, 20/30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, people with chronic conditions, pregnant women).
- During this period, approximately 13.2 million people aged 60 years and above received one COVID-19 vaccine dose. Of these, approximately 3.9 million people were aged 80 years.
- The median COVID-19 vaccination coverage among people aged 60 years and above was 7.4% (range: <0.1–52.8%), with high variation among countries. For people aged 80 years and above, the median coverage was 10.8% (range: <0.1–83.5%), with high variation among countries.
- Among the 20 reporting countries, one country reported a vaccination coverage ≥50% for the age group 60 years and above, while six countries reported a vaccination coverage ≥50% for the age group 80 years and above.
- Most of the approximately 15 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Pfizer BioNTech – Comirnaty JN.1 vaccine (around 10.6 million doses; 70.6% of the total doses administered).
